Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating. | Pharmaceuticals (Basel) | 2022 | 35337175 | PubTator, text mining | PubMed |
| Androgen Glucuronidation in Mice: When, Where, and How. | Biology (Basel) | 2022 | 35336777 | PubTator, text mining | PubMed |
| Personalized Management and Treatment of Alzheimer's Disease. | Life (Basel) | 2022 | 35330211 | PubTator, text mining | PubMed |
| Cannabinoids: Therapeutic Use in Clinical Practice. | Int J Mol Sci | 2022 | 35328765 | PubTator, text mining | PubMed |
| Identification of a Steroid Hormone-Associated Gene Signature Predicting the Prognosis of Prostate Cancer through an Integrative Bioinformatics Analysis. | Cancers (Basel) | 2022 | 35326723 | PubTator, text mining | PubMed |
| Genetic Variations on Redox Control in Cardiometabolic Diseases: The Role of Nrf2. | Antioxidants (Basel) | 2022 | 35326157 | PubTator, text mining | PubMed |
| Molecular targets of statins and their potential side effects: Not all the glitter is gold. | Eur J Pharmacol | 2022 | 35321818 | PubTator, text mining | PubMed |
| Value of UGT2B7-161 Single Nucleotide Polymorphism in Predicting the Risk of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Who Underwent Pertuzumab Combined with Trastuzumab Therapy by PSL. | Pharmgenomics Pers Med | 2022 | 35321089 | PubTator, text mining | PubMed |
| Pharmacometric Analysis of Intranasal and Intravenous Nalbuphine to Optimize Pain Management in Infants. | Front Pediatr | 2022 | 35311056 | PubTator, text mining | PubMed |
| A physiologically based pharmacokinetic model of clopidogrel in populations of European and Japanese ancestry: An evaluation of CYP2C19 activity. | Pharmacol Res Perspect | 2022 | 35307978 | PubTator, text mining | PubMed |
| Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17 and ABC1B polymorphisms on lamotrigine metabolism in Danish patients. | Epilepsy Res | 2022 | 35303539 | PubTator, text mining | PubMed |
| Clinical Importance of Potential Genetic Determinants Affecting Propofol Pharmacokinetics and Pharmacodynamics. | Front Med (Lausanne) | 2022 | 35295593 | PubTator, text mining | PubMed |
| Use of a Baculovirus-Mammalian Cell Expression-System for Expression of Drug-Metabolizing Enzymes: Optimization of Infection With a Focus on Cytochrome P450 3A4. | Front Pharmacol | 2022 | 35295333 | PubTator, text mining | PubMed |
| Pharmacokinetic drug interactions of asciminib with the sensitive cytochrome P450 probe substrates midazolam, warfarin, and repaglinide in healthy participants. | Clin Transl Sci | 2022 | 35293131 | PubTator, text mining | PubMed |
| Effects of genetic polymorphism of drug-metabolizing enzymes on the plasma concentrations of antiepileptic drugs in Chinese population. | Bioengineered | 2022 | 35290166 | PubTator, text mining | PubMed |
| Cenobamate for treatment-resistant focal seizures: current evidence and place in therapy. | J Cent Nerv Syst Dis | 2022 | 35282314 | PubTator, text mining | PubMed |
| Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma. | Front Cell Dev Biol | 2022 | 35281080 | PubTator, text mining | PubMed |
| The association between different hormone replacement therapy use and the incidence of lung cancer: a systematic review and meta-analysis. | J Thorac Dis | 2022 | 35280481 | PubTator, text mining | PubMed |
| Regulation of human UDP-glycosyltransferase (UGT) genes by miRNAs. | Drug Metab Rev | 2022 | 35275773 | PubTator, text mining | PubMed |
| Causal association evaluation of diabetes with Alzheimer's disease and genetic analysis of antidiabetic drugs against Alzheimer's disease. | Cell Biosci | 2022 | 35272707 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=23